Middle East Congress

1st American Diabetes Association

Middle East Congress Dubai, United Arab Emirates December 4-6, 2012 Endorsed by:

Co-hosted by:

In collaboration with EDC, Center for Diabetes Education


Middle East Congress

Under the patronage of His Highness Sheikh Hamdan bin Rashid Al Maktoum, Deputy Ruler of Dubai, UAE Minister of Finance and President of Dubai Health Authority.

Page 1


Middle East Congress A Welcome Message from Engineer Essa Al Hajj Al Maidoor On behalf of the Government of Dubai and the Dubai Health Authority, the strategic health authority for the Emirate of Dubai, we welcome you to the 1st American Diabetes Association Middle East Congress and to UAE, Dubai city. Over the last few years, Dubai has seen a phenomenal growth in the health sector. This has been possible because of the vision of His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice-President and Prime Minister of the UAE and Ruler of Dubai, His Highness Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum, Dubai Crown Prince and Chairman of the Dubai Executive Council and due to the directions of His Highness Sheikh Hamdan bin Rashid Al Maktoum, Deputy Ruler of Dubai, UAE Minister of Finance and President of the Dubai Health Authority. Keeping this vision in mind, the Dubai Health Authority is working at various levels to tackle diabetes. We recognize that diabetes is a major health concern globally and this region in particular. UAE now ranks 10th on the global map with regard to the prevalence of diabetes. Consolidated efforts are being carried out to manage diabetes and prevent more people from developing this disease. Therefore, we have strengthened the role of our primary healthcare centres so that the disease can be detected early on and so that pre-diabetics can avoid the onset of this disease through lifestyle modification. We have also completed the construction of a state-of-the-art Dubai Diabetes Centre which is an expansion of the current centre. The new centre has an enhanced capacity and is significantly larger in size. The centre will provide increased capacity for retinal imaging and podiatry. Moreover, the DHA has also introduced pediatric endocrinology services at the new centre, which is designed to be child-friendly. Thus, while on one hand we are expanding our services, on the other, we are enhancing our health educational campaigns which target various sections of the community. Hosting, attending and speaking at congresses such as this one, are an important part of our vision, as conferences provide a platform to discuss the latest advances in the field and are an effective medium for public outreach and awareness. With this, I wish you all the best and I look forward to your participation in the congress! Engineer Essa Al Hajj Al Maidoor Director General Dubai Health Authority

Page 2


Middle East Congress A Welcome Message from the American Diabetes Association and EDC, Center for Diabetes Education On behalf of the American Diabetes Association and EDC, Center for Diabetes Education, it gives us great pleasure to welcome you to the 1st American Diabetes Association Middle East Congress in Dubai, UAE. The program will focus on cuttingedge research and evidence-based strategies to prevent diabetes and improve outcomes in your patients. This forum will also be an excellent opportunity for the exchange of ideas and experiences with your colleagues from the Middle East. Diabetes continues to be a global epidemic, especially in the Middle East. According to the International Diabetes Federation’s Diabetes Atlas, at least five countries in the Middle East area will be among the top ten worldwide in prevalence of diabetes by the year 2030. The overarching goal of the Congress is to support the commitment of health care professionals in the Middle East in the fight against diabetes and their efforts on behalf of people with diabetes and their families. This educational meeting is also a continuation of the collaboration between the American Diabetes Association and the EDC, Center for Diabetes Education. For the past 10 years our organizations have been working together to provide educational opportunities for health care professionals in Egypt. We sincerely thank Engineer Essa Al Hajj Al Maidoor, Director of Dubai Health Authority for endorsing the 1st American Diabetes Association Middle East Congress. The involvement of the Dubai Health Authority in the Congress will immensely enhance the profile of the Congress. We would like also to extend our thanks to the Emirates Diabetes Society for cohosting the Congress and for their constant help.

M. Sue Kirkman, MD Senior Vice President, Medical Affairs and Community Information American Diabetes Association

Page 3

Mahmoud Ibrahim, MD Director, EDC, Center for Diabetes Education


Middle East Congress Table of Contents General Information......................................................................................................... Pages 5-6 Continuing Education

Target Audience....................................................................................................... Page 8

Learning Objectives................................................................................................ Page 8

Accreditation Statement...................................................................................... Page 8

Obtain Certificates of Attendance.................................................................. Page 8

1st Middle East Congress Planning Committee................................................. Page 9 1st Middle East Congress Abstract Reviewers................................................... Page 9 1st Middle East Congress Planning Committee Disclosures....................... Page 44 1st Middle East Congress Presenting Faculty Disclosures........................... Pages 45-46 1st Middle East Congress Oral Abstract Presenter Disclosures................. Pages 47-49 1st Middle East Congress Program Information

Tuesday, December 4............................................................................................. Page 10

Wednesday, December 5..................................................................................... Pages 11-18

Thursday, December 6.......................................................................................... Pages 19-26

Poster Session Abstracts Behavioral, Nutrition, Education, and Exercise......................................... Pages 27-28 Clinical Diabetes and Therapeutics................................................................. Pages 28-35 Complications and Cardiovascular Disease (CVD)................................. Pages 35-39 Epidemiology and Genetics................................................................................ Pages 39-42 Published Only Abstracts............................................................................................. Page 43 Corporate Symposia....................................................................................................... Page 50 Exhibitors...................................................................................................................... Pages 51-55 Product Theaters........................................................................................................ Page 56

Page 4


Middle East Congress General Information Abstracts The Special Supplement to the 1st Middle East Congress edition of Diabetes Care contains all the abstracts accepted for the Congress. The special supplement is provided free of charge and can be found in the attendee registration bag. Badges Each registered attendee and exhibitor attending the Middle East Congress will be issued an official identification badge. Anyone attending the sessions or wishing to enter session rooms, the Exhibit Hall, or Poster Hall, must wear a valid badge for entrance. You will be stopped and asked to present your badge, if it is not in view of security guards. If there are any errors on your badge, please visit Registration so it can be corrected.

Exhibit Hall Sheikh Rashid Hall, Exhibits Take advantage of the unique opportunity the Exhibit Hall provides to meet one-on-one with company representatives and learn how their products and services can help you improve your practice or laboratory. Hours of operation: Tuesday, December 4.................................18.00–21.00 Wednesday, December 5..........................10.00–17.00 Thursday, December 6...............................10.00–17.00 Exhibit Hall Breaks Sheikh Rashid Hall, Exhibits Wednesday, December 5 11.30-12.30 Visit exhibitors, view posters and attend a Product Theater demonstration by Sweet Stevia. 14.30-15.30 Visit exhibitors, view posters and attend a Product Theater demonstration by Pfizer.

Business Center Spectrum Digital Print Concourse 1, between Exhibition Halls 2 and 3 The Business Center offers a range of services: • Conference and Workshop Package (CD, DVD Copy, Tent Cards, Folder, Invitations and Stationery) • Business Cards • Internet Access • Posters • Presentation Material • Binding

Thursday, December 6 11.30-12.30 Visit exhibitors and view posters. 14.30-15.30 Visit exhibitors, view poster and attend a Product Theater demonstration by Boehringer-Ingelheim and Eli Lilly and Company Diabetes Alliance

Hours of operation: Tuesday, December 4.................................08.30–19.30 Wednesday, December 5..........................08.30–19.30 Thursday, December 6...............................08.30–19.30

First Aid Station Main Concourse, next to Exhibit Hall 5

Email Stations Supported by Bristol-Meyers Squibb/AstraZeneca Email stations are located in the Exhibit Hall at the Internet Kiosk. Utilize the stations to keep in touch with the office as well as your personal business.

If you require assistance during your time at the Dubai World Trade Center, please call (0)4 306 4040 to speak to the on-duty medic or call the Command Control Centre at (0)4 306 4600/ (0)4 308 6212 for assistance. If you do not have a telephone, you can speak to the nearest member of the security staff, who will assist you. The EMS team is available one hour prior to the start of the event to one hour after event closure. Please also note that EMS will arrange for an ambulance if there is a need to transport a patient or an injured person to the hospital.

Page 5


Middle East Congress General Poster Sessions Sheikh Rashid Hall

Opening Reception Sheikh Rashid Hall

Posters will be displayed continuously Wednesday and Thursday. Poster presenters will be available for discussion at their posters during four General Poster Sessions, scheduled from 11.30 to 12:30 and 14.30 to 15.30 on Wednesday and Thursday.

Join us in Sheikh Rashid Hall Tuesday evening from 18.00 to 20.00 for the Opening Reception. Exchange ideas or informally share best practices with your colleagues. Light refreshments and beverages will be provided.

Lost and Found The Lost and Found Office is located on Level 1, above Hall 8, and is responsible for the safekeeping of items that have been found on the premises. Items will be returned to the rightful owner upon presentation of reasonable proof of ownership. The Lost and Found Office operates 24 hours, 7 days a week.

Prayer Rooms The men’s prayer room is located on level 2 opposite Exhibition Hall 5 and the ladies’ prayer room is located on level 2 opposite Exhibition Hall 7. An additional ladies’ prayer room is also available near Sheikh Saeed Halls. Registration In Front of Sheik Rashid Hall

Tel: (0)4 306 4600

Hours of operation:

Media/Press Room Dubai Room A

Tuesday, December 4.................................08.30–18.00 Wednesday, December 5..........................08.00–17.00 Thursday, December 6...............................08.00–16.00

Hours of Operation: Tuesday, December 4.................................10:00-17:00 Wednesday, December 5..........................10:00-17:00 Non-Smoking Policy As per Dubai Municipality law, the entire complex has been declared non-smoking. A fine will be charged to all violators. Smoking is only allowed in designated areas outdoors.

Speaker Ready Room The Speaker Ready Room is reserved for use by those presenting at the Congress. Speakers are required to check in a minimum of 4 hours before their presentation. Computer workstations will be available for any last minute updates to presentations. Hours of operation: Tuesday, December 4.................................10.00–17.30 Wednesday, December 5..........................09.00–17.00 Thursday, December 6...............................09.00–17.00

Page 6


Middle East Congress

Commercial Support Corporate Symposia Bristol-Myers Squibb and AstraZeneca Coca-Cola MSD Novo Nordisk Pfizer Email Stations Bristol-Myers Squibb and AstraZeneca Lanyards MSD Product Theaters Boehringer Ingelheim/Lilly Pfizer Sweet Stevia Registration Bags Merck Serono

Page 7


Middle East Congress Learning Objectives and Target Audience All health care professionals and researchers involved in diabetes research or the delivery of diabetes care and services will benefit from the program of the 1st American Diabetes Association Middle East Congress. At the conclusion of this Congress, attendees will be able to: • Assess recent data regarding novel concepts in the pathophysiology and prevention of diabetes and cardiovascular disease related disorders • Discuss the latest evidence-based strategies for management of type 2 diabetes • Interpret data from the latest clinical trials for application to clinical practice • Explore educational strategies for preventing diabetes and its complications • Assess the latest research related to the diabetic foot and painful diabetic neuropathy • Indicate the latest research regarding effective therapies for treating diabetic kidney disease • Explain the effect of diabetes on oral health and how to optimize the outcome • Analyze data from studies regarding the management of pediatric type 1 and type 2 diabetes • Discuss current issues related to incretin based therapies in patients with diabetes • List strategies for managing diabetes with new strategies including bariatric surgery

Accreditation Statement Physicians The American Diabetes Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Diabetes Association designates this live activity for a maximum of 12.0 AMA PRA Category 1 credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Obtain Certificates of Attendance/Continuing Education Certificates of Attendance/Continuing Education are provided to registered attendees based upon the completion of the online evaluation that will be available at www.ada-me.org through December 21, 2012. For questions regarding continuing education, please contact [email protected].

Page 8


Middle East Congress 1st Middle East Congress Meeting Planning Committee The 1st Middle East Congress Meeting Planning Committee is responsible for the development and content of the meeting. The American Diabetes Association and EDC would like to thank the members of the committee for their hard work and dedication: Muhammad Abdul-Ghani

Peter Gaede

Abdulrazzak Al Madani

Edward Gregg

Heba Al Shaar

Mahmoud Ibrahim (Chair)

Stuart Baird

Mick Kumwenda

Jason Baker

Christine Skinner

Wenche S. Borgnakke

Abraham Thomas

Mohamed Farghaly

Jaakko Tuomilehto

Martha Funnell

1st Middle East Congress Abstract Reviewers The 1st Middle East Congress Meeting Planning Committee, the American Diabetes Association, and EDC would like to thank the following abstract reviewers for their contributions to this year’s Congress: Abdulrazzak Al Madani (Chair) Megahed Abu Almagd Bachar Afandi Elham Alamiri Jaber Al Ansari Monira Al Arouji Fatheya Al Awadi Abdullah Al Hamaq Khalid Aljabri Jamal Aljubeh Jumaa Alkaabi Nawal Almutawa Ali Baqir Abdulla Ben-Nakhi Salem Beshyah Asma Deeb Ali Elhouni Huda Ezzeddin

Page 9

Muhammad H. Farooqi Jihad Haddad Ahmed Hassoun Shashank Joshi Walid Kaplan Sehnaz Karadeniz Ali Khalil Iyad Kssiery Anoop Misra Anant Nigam Hussein Saadi Bashir Salih Duha Shaheen Samad Shera Amir-Kamran Nikousokhan Tayar Nihal Thomas Temel Yilmaz


Middle East Congress Tuesday, December 4, 2012 10.30-11.30 Opening Ceremony Sheik Rashid Hall, Room C-D 16.00–18.00 Symposium Opening Session Keynote Lectures Co-Chairs: Abdulrazzak Al Madani (UAE), and Abdullah Ben-Nakhi (Kuwait) Sheikh Rashid Hall, Room C–D 16.00–16.30 Diabetes in the Arab Countries Mahmoud Ibrahim (USA) 16.30–17.00 Metabolic Basis of Cardiovascular Disease Prevention Robert Eckel (USA) 17.00–17.30 Diabetes and Cancer Harold Lebovitz (USA) 17.30–18.00 Painful Neuropathy Andrew J.M. Boulton (UK)

18.00–20.00 Opening Reception Sheik Rashid Hall—Exhibits

Page 10


Middle East Congress Wednesday, December 5, 2012 10.00–11.30 Symposia State of the Art Lectures Co-Chairs: Ahmed Hassoun (UAE), and Anant Nigam (India) Sheikh Rashid Hall, Room C–D 10.00–10.30 New Frontiers in Weight Management Abraham Thomas (USA) 10.30–11.00 Hypoglycaemia—Are We Misinterpreting the Data? Philip Home (UK) 11.00–11.30 Diabetic Nephropathy Peter Gaede (Denmark) Diabetes and Cardiovascular Disease (1) Co-Chairs: Ali Khalil (UAE), and Megahed Abu Almagd (Egypt) Sheikh Rashid Hall, Room A 10.00–10.25 Obesity and Diabetes—Strategies to Optimize Cardiovascular Health Marc Evans (UK) 10.25–10.50 Cardiovascular Disease in Type 1 Diabetes—Is the Complication the Same as in Type 2 Diabetes? Robert Eckel (USA) 10.50–11.15 Insulin Therapy and Cardiovascular Disease Outcome Andreas Liebl (Germany) 11.15–11.30 Panel Discussion Oral Presentations Clinical Diabetes and Therapeutics..............................................Abstracts 1-OR to 6-OR Co-Chairs: Ali Baqir (UAE), and Jaber Al Ansari (UAE) Sheikh Rashid Hall, Room B

With State of the Art Lecture Treatment of Postprandial Hyperglycemia, Impact on Long Term Complications Oliver Schnell (Germany)

Page 11


Middle East Congress Wednesday, December 5, 2012 12.30–14.30 Symposia Late Breaking Clinical Trials Co-Chairs: Abdullah Al Hamaq (Qatar), and Salem Beshyah (UAE) Sheikh Rashid Hall, Room C–D 12.30–12.55 ORIGIN, TODAY and SEARCH Abraham Thomas (USA) 12.55–13.20 TINSAL-Type 2 Diabetes-Type 1 Exchange Jason Baker (USA) 13.20–13.45 Diabetes and Inflammation Clinical Trials Harold Lebovitz (USA) 13.45–14.10 Steno-2 Study, New Projections Peter Gaede (Denmark) 14.10–14.30 Panel Discussion Diabetes and Cardiovascular Disease (2) Co-Chairs: Amir-Kamran Nikousokhan Tayar (Iran), and Jamal Aljubeh (UAE) Sheikh Rashid Hall, Room A 12.30–12.55 Self-Monitoring of Glucose—Impact of Cardiovascular Risk in Diabetes Oliver Schnell (Germany) 12.55–13.20 Fibrate and Statin Therapy—Where Do We Stand? Robert Eckel (USA) 13.20–13.45 GLP-1-Based Therapy—Potentials to Reduce Cardiovascular Outcome Carol Wysham (USA) 13.45–14.10 Tight Glycemic Control and Cardiovascular Disease Outcome Stefano Del Prato (Italy) 14.10–14.30 Panel Discussion Oral Presentations Clinical Diabetes and Therapeutics.............................................. Abstracts 7-OR to 14-OR Co-Chairs: Temel Yilmaz (Turkey), and Bachar Afandi (UAE) Sheikh Rashid Hall, Room B

With State of the Art Lecture The ABCD Algorithm and Personalized Therapy in Type 2 Diabetes Paolo Pozzilli (Italy)

Page 12


Middle East Congress Wednesday, December 5, 2012 15.30–17.00 Symposium New Diabetes Treatments Co-Chairs: Monira Al Arouj (Kuwait), and Iyad Kssiery (UAE) Sheikh Rashid Hall, Room C–D 15.30–15.55 Non Insulin Injectables Carol Wysham (USA) 15.55–16.20 SGLT2 Inhibition Mick Kumwenda (UK) 16.20–16.45 Future of Insulin Therapy Peter Gaede (Denmark) 16.45–17.00 Panel Discussion Oral Presentations Epidemiology and Genetics.............................................................. Abstracts 15-OR to 19-OR Co-Chairs: Bashir Salih (UAE), and Nihal Thomas (India) Sheikh Rashid Hall, Room A

With State of the Art Lecture Immunotherapy of Type 1 Diabetes—New Perspectives Paolo Pozzilli (Italy)

Behavioral, Nutrition, Education, and Exercise...................... Abstracts 20-OR to 24-OR Co-Chairs: Ali Elhouni (UAE), and Asma Deeb (UAE) Sheikh Rashid Hall, Room B

With State of the Art Lecture Nutrition Education Lurelean Gaines (USA)

Page 13


Middle East Congress Wednesday, December 5, 2012 10.00–11.30 Session: Clinical Diabetes and Therapeutics Co-Chairs: Ali Baqir (UAE), and Jaber Al Ansari (UAE) Sheikh Rashid Hall, Room B 10.00–10.18 State of the Art Lecture 1-OR

Treatment of Postprandial Hyperglycemia, Impact on Long Term Complications Oliver Schnell (Germany) 10.18-10.30 Type of Insulin and Age are Predictors of Hospitalization due to Severe Hypoglycemia: The EpiHypo Study T. Saukkonen, S. Mäkimattila, P. Korhonen, J. Haukka, P. Pajunen, F. Hoti Espoo, Finland

10.30-10.42 The Effectiveness and Safety of Starting Biphasic Insulin Aspart 30 (Premix) in Older vs. Younger Adults with Type 2 Diabetes (T2DM): Results from the A1chieve Study Siddharth N. Shah1, Yuxiu Li2, Zanariah Hussein3, Mohammad E. Khamseh4, Ole Bech5, Su Yen Goh5, Samir H. Assaad-Khalil6 1 Mumbai, India, 2,5Beijing, China, 3Putrajaya, Malaysia, 4Tehran, Iran, 5Singapore, Indonesia, 6 Alexandria, Egypt 2-OR

10.42-10.54 200 U/ml Insulin Degludec Improves Glycemic Control Similar to Insulin Glargine with a Low Risk of Hypoglycemia in Insulin-Naïve People with Type 2 Diabetes Richard Bergenstal1, Anuj Bhargava2, Rajeev Jain3, Søren Rasmussen4, Azhar Rana4, Stephen Gough5 1 Minneapolis, MN, USA, 2Des Moines, IA, USA, 3Milwaukee, WI, USA, 4Søborg, Denmark, 5Oxford, UK

3-OR

4-OR

10.54-11.06 Impact of Different Timing of Insulin Delivery in a 23-Hour Clinical Trial with the International Artificial Pancreas (IAP) Control Algorithm F. Di Palma, A. Avogaro, C. Benesch, D. Bruttomesso, J.H. DeVries, W. Doll, G. De Nicolao, S. Del Favero, L. Heinemann, R. Hovorka, L. Leelarathna, Y.M. Luijf, J. Mader, M. Nodale, J. Place, E. Renard, P. Soru, C. Toffanin, L. Magni, C. Cobelli, on behalf of the AP@home Consortium

11.06-11.18 Efficacy and Safety of Insulin Detemir and Biphasic Insulin Aspart 30 in Patients with Type 2 Diabetes in the Middle East and Gulf Region: Results from the A1chieve Study Jihad Haddad1, Mohammad E. Khamseh2, Rachid Malek3, Nabil K. El Naggar4, Vinay Prusty5, Philip Home6 1 Amman, Jordan, 2Tehran, Iran, 3Sétif, Algeria, 4Jeddah, Saudi Arabia, 5Zürich, Switzerland, 6 Newcastle upon Tyne, UK 11.18-11.30 6-OR The Novel Therapeutic Effect of PI3Kγ Inhibition in Type 1 Diabetes Jamil Azzi Boston, MA, USA

5-OR

Page 14


Middle East Congress Wednesday, December 5, 2012 12.30–2.30 Session: Clinical Diabetes and Therapeutics Co-Chairs: Temel Yilmaz (Turkey), and Bachar Afandi (UAE) Sheikh Rashid Hall, Room B 12.30–12.50 State of the Art Lecture The ABCD Algorithm and Personalized Therapy in Type 2 Diabetes Paolo Pozzilli (Italy) 12.50–13.02 Factors Associated with Weight Gain in Type 2 Diabetic Patients Starting on Insulin: The CREDIT Study Beverley Balkau1, Philip Home2, Edward Wang3, Michel Marre4 1 Villejuif, France, 2Newcastle upon Tyne, UK, 3Bridgewater, NJ, USA, 4Paris, France

7-OR

13.02–13.14 Evaluating the Clinical and Cost Effectiveness and Patient Preference of Incretin Therapies When Used in Accordance with National Guidelines in Routine UK Primary Care Practice Marc Evans1, Phil McEwan2, Richard O’Shea1, Alison Clarke1, Lindsay George1 1 Cardiff UK, 2Swansea, UK

8-OR

13.14–13.26 9-OR Changing from NPH Insulin to Biphasic Insulin Aspart 30 is Associated with Improved Quality of Life and Glycaemic Control in People with Type 2 Diabetes: A1chieve Study Data Salah El Ghazaly Harb1, Mohammad E. Khamseh2, Wenying Yang3, Philip Home4, Siddharth Shah5, Vinay Prusty6, Zafar Latif7 1 Cairo, Egypt, 2Tehran, Iran, 3Beijing, China, 4Newcastle upon Tyne, UK, 5Mumbai, India, 6 Zürich, Switzerland, 7Dhaka, Bangladesh 13.26–13.38 10-OR Prospectively Planned Meta-Analysis Comparing Hypoglycemia Rates of Insulin Degludec with those of Insulin Glargine Stephen Gough1, Chantal Mathieu2, Stefano Del Prato3, Bruce W. Bode4, Henriette Mersebach5, Lars Endahl5, Bernard Zinman6 1 Oxford, UK, 2Leuven, Belgium, 3Pisa, Italy, 4Atlanta, GA, USA, 5Søborg, Denmark, 6Toronto, ON, Canada 13.38–13.50 11-OR Improved Pancreatic Beta Cell Function in Type 2 Diabetes by Insulin Pump Therapy for 6 Years Soo-Bong Choi, Hyun-Ju An, Kyung-Jin Kim, Yun-Hee Noh Seoul, Korea (Continued on Next Page)

Page 15


Middle East Congress Wednesday, December 5, 2012 13.50–14.02 Starting Insulin Aspart is Associated with Improved Quality of Life Regardless of Age: Findings from the A1chieve Study Nabil K. El Naggar1, Philip Home2, Rachid Malek3, Zafar A. Latif4, Ole M. Bech5, Su-Yen Goh6 1 Jeddah, Saudi Arabia, 2Newcastle upon Tyne, UK, 3Sétif, Algeria, 4Dhaka, Pakistan, 5Beijing, China, 6Singapore, Malaysia 14.02–14.14 13-OR Triple Combination (Insulin Glargine+Sitagliptin+Metformin) Improves Glycemic Control in Patients with T2DM: EASIE Extension Juliana Chan1, Pablo Aschner2, David Owens3, Sylvie Picard4, Edward Wang5, Marie-Paule Dain6, Valérie Pilorget6, Akram Echtay7, Vivian Fonseca8 1 Hong Kong, China, 2Bogotá, Colombia, 3Cardiff, UK, 4Dijon, France, 5Bridgewater, NJ, USA, 6 Paris, France, 7Beirut, Lebanon, 8New Orleans, LA, USA

12-OR

14.14–14.26 Glycemic Control and Safety of Insulin Glargine Among Type 1 Diabetes Patients in the United States: An Analysis of the IMPACT Database Peter Chase1, Edward Wang2, Anna Cali3, Marie-Paul Dain3, Jay Lin4, Satish Garg1 1 Aurora, CO, USA, 2Bridgewater, NJ, USA, 3Paris, France, 4Flemington, NJ, USA 14-OR

Page 16


Middle East Congress Wednesday, December 5, 2012 15.30–17.00 Session: Epidemiology and Genetics Co-Chairs: Bashir Salih (UAE), and Nihal Thomas (India) Sheikh Rashid Hall, Room A 15.30–16.00 State of the Art Lecture Immunotherapy of Type 1 Diabetes—New Perspectives Paolo Pozzilli (Italy) 16.00–16.12 Glycemic Control and Hypoglycemia Prevalence According to BMI: An Analysis of RCT Data Carmine G. Fanelli1, Francesca Porcellati1, Jay Lin2, Edward Wang3, Paolo Lucidi1, Geremia B. Bolli1 1 Perugia, Italy, 2Flemington, NJ, USA, 3Bridgewater, NJ, USA

15-OR

16.12–16.24 16-OR A Pilot Study of Diagnosed and Undiagnosed Type 2 Diabetic Patients in Qatar Dennis O. Mook-Kanamori1, Mohammed M. El-Din Selim1, Marjonneke J. Mook-Kanamori1, Mahmoud A. Zirie1, Hala Al-Homse1, Amina Al-Obaidli1, Khoulood A.S. Al-Mahmoud2, Jillian Rowe1, Wafaa Gerbi1, Omar Chidiac1, Sara A. Kader1, Wadha Al Muftah1, Ahmed H. Takiddin1, Cindy McKeon1, Karsten Suhre1,2 1 Doha, Qatar, 2Neuherberg, Germany

17-OR

16.24–16.36 Quality Improvement of Diabetes Care Using National Diabetes Register Eva Törnvall, Ing-Marie Hallgren, Ewa Grodzinsky Linköping, Sweden

18-OR

16.36–16.48 Minimal Criteria for Genetic Screening of MODY in Children F. Cardella, F. Navarra, R. Roppolo, F. La Rocca, A.M. Tranchida, G. Corsello Palermo, Italy

16.48–17.00 19-OR Retrospective Analysis of Characteristics of Patients Attending Emergency Department of National Institute of Diabetes and Endocrinology in Cairo, Egypt A. Bassyouni, I. El Ebrashy, G. Salem, A. El Kocy, A. Abdella, A. Ahfoz, S. Amam Cairo, Egypt

Page 17


Middle East Congress Wednesday, December 5, 2012 15.30–17.00 Session: Behavioral, Nutrition, Education, and Exercise Co-Chairs: Ali Elhouni (UAE), and Asma Deeb (UAE) Sheikh Rashid Hall, Room B 15.30–16.00 State of the Art Lecture Nutrition Education Lurelean Gaines (USA) 16.00–16.12 Self-Management Comparison of Adults with Type 1 Diabetes in Latin America and the Middle East: Data from the International Diabetes Management Practices Survey (IDMPS) Juan Jose Gagliardino1, Pablo Aschner2, Juliana Chan3, Jean-Marc Chantelot4, Elizabeth Genestin4, Marie-Paule Dain4, Hasan Ilkova5, Fernando Javier Lavalle-González6, Ambady Ramachandran7, IDMPS Investigators 1 La Plata, Argentina, 2Bogotá, Colombia, 3Hong Kong, China, 4Paris, France, 5Istanbul, Turkey, 6 Monterrey, Mexico, 7Chennai, India

20-OR

21-OR WITHDRAWN 16.12-16.24 22-OR Ain Shams University Diabetes Education Experience (ASU-DEE): A Trial for a Structural Educational Program for Egyptian People with Diabetes Mona Mohamed Abdelsalam, H.A.H. Elorabi, Y.M. Eid, S.I. Sahmoud Cairo, Egypt 16.24-16.36 23-OR Dietary Knowledge, Attitude and Practice of Female Diabetic School Teachers in Jeddah, Saudi Arabia Amani Aliwi Alrasheedi, Nadia Saleh Alamoudi Jeddah, Saudi Arabia 16.36-16.48 24-OR Challenges in Type 1 Diabetes: Can Structure Diabetes Education Evolve to Meet Them? DAFNE in Kuwait Etab Taghadom, Jumana Alkandri, Maryam Alhamad, Sumayaa Al Ebrahim, Ebaa Al Ozairi Kuwait City, Kuwait

Page 18


Middle East Congress Thursday, December 6, 2012 10.00–11.30 Symposium Diabetes Education Co-Chairs: Khalid Aljabri (UAE), and Jumaa Alkaabi (UAE) Sheikh Rashid Hall, Room C–D 10.00–10.25 Education and Prevention—Lessons from the Finnish Study Jaakko Tuomilehto (Finland) 10.25–10.50 Treatment of Non-Compliance Marc Evans (UK) 10.50–11.15 Educating the Educator Lurelean Gaines (USA) 11.15–11.30 Panel Discussion Oral Presentations Behavioral, Nutrition, Education, and Exercise........................ Abstracts 25-OR to 30-OR Co-Chairs: Christine Skinner (UK), and Nawal Almutawa (UAE) Sheikh Rashid Hall, Room A

With State of the Art Lecture Diabetic Foot at Primary Care Level Stuart Baird (UK)

Clinical Diabetes and Therapeutics................................................ Abstracts 31-OR to 36-OR Co-Chairs: Huda Ezzeddin (UAE), and Tarek Fiad (UAE) Sheikh Rashid Hall, Room B

With State of the Art Lecture Double Diabetes—A New Clinical Entity Paolo Pozzilli (Italy)

Page 19


Middle East Congress Thursday, December 6, 2012 12.30–14.30 Current Issues Debate Session Co-Chairs: John E. Anderson (USA), and Mahmoud Ibrahim (USA) Sheikh Rashid Hall, Room C–D 12.30–13.10 AIC, Effective Diagnostic Tool? Yes Mick Kumwenda (UK) No Peter Gaede (Denmark) 13.10–13.50 Bariatric Surgery Should be the First Option in Morbid Obese Diabetics Yes Carol Wysham (USA) No Jason Baker (USA) 13.50–14.30 PPAR Agonists—Still a Clinically Significant Role? Yes Philip Home (UK) No Jaakko Tuomilehto (Finland) Symposium Diabetes and Oral Health Supported by an unrestricted educational grant from Colgate-Palmolive Company Co-Chairs: Muhammad H. Farooqi (UAE), and Walid Kaplan (UAE) Sheikh Rashid Hall, Room A 12.30–12.55 Effect of Diabetes on Periodontal Disease Steven Engebretson (USA) 12.55–13.20 Effect of Periodontal Disease on Diabetes Wenche S. Borgnakke (USA) 13.20–13.45 Treatment of Periodontitis—Effect on Glycemic Control Yousef S. Khader (Jordan) 13.45–14.10 Effect of Full-Mouth Extractions and Dental Implants Placement on Glycemic Control Amin ur Rahman (UAE) 14.10–14.30 Panel Discussion Oral Presentations Diabetes in the United Arab Emirates......................................... Abstracts 37-OR to 44-OR Co-Chairs: Salah Abusnana (UAE), and Mohamed Farghaly (UAE) Sheikh Rashid Hall, Room B

With State of the Art Lecture Status of Diabetes in the United Arab Emirates Abdulrazzak Al Madani (UAE) Page 20


Middle East Congress Thursday, December 6, 2012 15.30–17.00 Symposia Women with Diabetes Co-Chairs: Hussein Saadi (UAE), and Duha Shaheen (UAE) Sheikh Rashid Hall, Room C–D 15.30–15.55 Cardiovascular Disease Outcome in Women with Diabetes John E. Anderson (USA) 15.55–16.20 Gestational Diabetes Martha Funnell (USA) 16.20–16.45 Babies of Diabetic Women Jason Baker (USA) 16.45–17.00 Panel Discussion Diabetes in the Middle East Co-Chairs: Abdullah Ben-Nakhi (Kuwait), and Abdullah Al Hamaq (Qatar) Sheikh Rashid Hall, Room B 15.30–15.45 Iran Amir-Kamran Nikousokhan Tayar (Iran) 15.45–16.00 Kuwait Monira Al Arouj (Kuwait) 16.00–16.15 Egypt Megahed Abu Almagd (Egypt) 16.15–16.30 Saudi Arabia Khaled Abdullah Tayeb (Saudi Arabia) 16.30–16.45 Jordan Jihad Haddad (Jordan) 16.45–17.00 Turkey Sehnaz Karadeniz (Turkey) Oral Presentations Diabetes Complications and Cardiovascular Disease................Abstracts 45-OR to 50-OR Co-Chairs: Elham Alamiri (UAE), and Mick Kumwenda (UK) Sheikh Rashid Hall, Room A

With State of the Art Lecture Glucose Toxicity and Diabetes Complications Mick Kumwenda (UK)

Page 21


Middle East Congress Thursday, December 6, 2012 10.00–11.30 Session: Behavioral, Nutrition, Education, and Exercise Co-Chairs: Christine Skinner (UK), and Nawal Almutawa (UAE) Sheikh Rashid Hall, Room A 10.00–10.20 State of the Art Lecture Diabetic Foot at Primary Care Level Stuart Baird (UK) 25-OR

10.20–10.32 Self-Reported Knowledge of Diabetes among High School Students in Al-Amirat and Qurayat–Muscat–Sultanate of Oman, 2011 Thamra Al Ghafri, Badriya Al-Mahrooqi, Rahma Al-Hadrami, Aida Al-Smaili, Hadia Al-Lawati, Asma Al-Shidhani, Khawla Al-Hooti, Amal Al-Amri, Saif Al-Tamimi Muscat, Oman

10.32–10.44 26-OR IER3 Deficiency Inhibits Diet-Induced Phenotypic Switch in Adipose Tissue Macrophages and Protects Against Obesity Mohd Shahid, Ammar A. Javed, Haley Ramsey, Warren M. Zapol, Mei X. Wu Boston, MA, USA 10.44–10.56 27-OR Diabetes Prevention and Management in Physical Therapy Practice: A Call to Action Hamzeh Awad1, Ahmad Alghadir1, Elizabeth Dean2 1 Riyadh, Saudi Arabia, 2British Columbia, BC, Canada 10.56–11.08 28-OR Accuracy and Large Inaccuracy of Two Continuous Glucose Monitoring Systems L. Leelarathna, M. Nodale, J.M. Allen, D. Elleri, K. Kumareswaran, A. Haidar, K. Caldwell, M.E. Wilinska, C.L. Acerini, M.L. Evans, H.R. Murphy, D.B. Dunger, R. Hovorka Cambridge, UK 11.08–11.20 Comparison of Self-Perceived Oral Health, Periodontal Inflammatory Conditions and Socioeconomic Status in Individuals With and Without Prediabetes Fawad Javed Riyadh, Saudi Arabia 11.20–11.30 30-OR Health Promotion for Individual Behavior Change to Prevent Diabetes Faithy D. Wren Athens, TX, USA 29-OR

Page 22


Middle East Congress Thursday, December 6, 2012 10.00–11.30 Session: Clinical Diabetes and Therapeutics Co-Chairs: Huda Ezzeddin (UAE), and Tarek Fiad (UAE) Sheikh Rashid Hall, Room B 10.00–10.20 State of the Art Lecture Double Diabetes—A New Clinical Entity Paolo Pozzilli (Italy) 10.20–10.32 31-OR In T2D Patients with Baseline A1c